Stay updated on CDX-0159 Phase 1 Clinical Trial

Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CDX-0159 Phase 1 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A notice banner announces an NIH website transition and says “Super Intelligence” (SI) is replacing “Artificial Intelligence” (AI) in some NIH content.
    Difference
    1%
    Check dated 2026-10-25T01:25:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:08:34.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T01:38:13.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a footer that includes 'Revision: v3.7.0', indicating the page is not accessible.
    Difference
    16%
    Check dated 2026-09-20T00:25:13.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This reflects a new page build.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:07.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.4 to v3.6.5. This indicates a minor release of the site's page template and does not alter study information.
    Difference
    0.1%
    Check dated 2026-08-08T19:16:18.000Z thumbnail image

Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.